Small-molecule
impurities, such as N-nitrosodimethylamine
(NDMA), have infiltrated the generic drug industry, leading to recalls
in commonly prescribed blood pressure and stomach drugs in over 43
countries since 2018 and directly affecting tens of millions of patients.
One promising strategy to remove small-molecule impurities like NDMA
from drug molecules is by size exclusion, in which the contaminant
is removed by selective adsorption onto a (micro)porous material due
to its smaller size. However, current solution-phase size-exclusion
separations are primarily limited by the throughput-selectivity trade-off.
Here, we report a bioinspired solution to conquer these critical challenges
by leveraging the assembly of atomically precise building blocks into
hierarchically porous structures. We introduce a bottom-up approach
to form micropores, mesopores, and macroscopic superstructures simultaneously
using functionalized oxozirconium clusters as building blocks. Further,
we leverage recent advances in photopolymerization to design macroscopic
flow structures to mitigate backpressure. Based on these multiscale
design principles, we engineer simple, inexpensive devices that are
able to separate NDMA from contaminated drugs. Beyond this urgent
model system, we expect this design strategy to open up hitherto unexplored
avenues of nanomaterial superstructure fabrication for a range of
size-exclusion purification strategies.